Prof. Yitshak Kreiss, Director-General of Sheba Medical Center, toured the Peter MacCallum Cancer Foundation in Melbourne Australia last week.
The Peter Mac-led POPSTAR II clinical trial, which will compare two cutting-edge treatments for men with advanced prostate cancer, is scheduled to open in early 2023 and will expand internationally to include patients in Israel and the Middle East. This agreement further strengthens Peter Mac’s growing relationship with Sheba Medical Center.